Dianthus Therapeutics

DNTHNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.396 B

$96.47 -0.35%

Close of 21 Sept 2026

Revenue

$2.04M

#3416 by revenue

Earnings

-$162.3M

Loss-making

Shares outstanding

55,934,378

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#52Cogent BiosciencesCOGT$5.55B
#53Ptc TherapeuticsPTCT$5.45B
#54Dianthus TherapeuticsDNTH$5.40B
#55ErascaERAS$5.26B
#56GrifolsGRFS$5.06B

What if Dianthus Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$541,242.35

Per share 5,610× higher

Bitcoin $1.72T

$30,746.81

Per share 319× higher

Nvidia $5.48T

$97,969.41

Per share 1,016× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Dianthus Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.